Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants inAPC,BRAF, andKTM2D
- 1 March 2020
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 30 (3), 380-388
- https://doi.org/10.1089/thy.2019.0561
Abstract
Background: Familial adenomatous polyposis (FAP) is a condition typically caused by pathogenic germline mutations in the APC gene. In addition to colon polyps, individuals with FAP have a substantially increased risk of developing papillary thyroid cancer (PTC). Little is known about the events underlying this association, and the prevalence of somatic “second-hit” mutations in APC is controversial. Methods: Whole-genome sequencing was performed on paired thyroid tumor and normal DNA from 12 FAP patients who developed PTC. Somatic mutation profiles were compared with clinical characteristics and previously sequenced sporadic PTC cases. Germline variant profiling was performed to assess the prevalence of variants in genes previously shown to have a role in PTC predisposition. Results: All 12 patients harbored germline mutations in APC, consistent with FAP. Seven patients also had somatic mutations in APC, and seven patients harbored somatic mutations in KMT2D, which encodes a lysine methyl transferase. Mutation of these genes is extremely rare in sporadic PTCs. Notably, only two of the tumors harbored the somatic BRAF p.V600E mutation, which is the most common driver mutation found in sporadic PTCs. Six tumors displayed a cribriform–morular variant of PTC (PTC-CMV) histology, and all six had somatic mutations in APC. Additionally, nine FAP-PTC patients had rare germline variants in genes that were previously associated with thyroid carcinoma. Conclusions: Our data indicate that FAP-associated PTCs typically have distinct mutations compared with sporadic PTCs. Roughly half of the thyroid cancers that arise in FAP patients have somatic “second-hits” in APC, which is associated with PTC-CMV histology. Somatic BRAF p.V600E variants also occur in some FAP patients, a novel finding. We speculate that in carriers of heterozygous pathogenic mutations of tumor suppressor genes such as APC, a cooperating second-hit somatic variant may occur in a different gene such as KTM2D or BRAF, leading to differences in phenotypes. The role of germline variance in genes other than APC (9 of the 12 patients in this series) needs further research.Keywords
This publication has 47 references indexed in Scilit:
- Deciphering Signatures of Mutational Processes Operative in Human CancerCell Reports, 2013
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Clinical curiosity: Cribriform‐morular variant of papillary thyroid carcinomaHead & Neck, 2006
- The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascadeHuman Molecular Genetics, 2002
- Aspiration and imprint cytopathology of thyroid carcinoma associated with familial adenomatous polyposisDiagnostic Cytopathology, 2000
- Genetics and Clinicopathological Findings in Thyroid Carcinomas Associated with Familial Adenomatous PolyposisThe American Journal of Pathology, 1999
- Somatic Mutation of theAPCGene in Thyroid Carcinoma Associated with Familial Adenomatous PolyposisJapanese Journal of Cancer Research, 1999
- Familial Adenomatous Polyposis-Associated Thyroid Cancer: A Clinical, Pathological, and Molecular Genetics StudyThe American Journal of Pathology, 1999
- The ret/ptc1 Oncogene Is Activated in Familial Adenomatous Polyposis-Associated Thyroid Papillary CarcinomasJournal of Clinical Endocrinology & Metabolism, 1998